RB
Robert Burns HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
121
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Assumed
| $7 |
63%
upside
| 1 | -25% |
0
%
| 20 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $7 |
70%
upside
| 2 | +91% |
0
%
| 16 Oct ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $5 |
55%
upside
| 3 | +90% |
0
%
| 23 Sep ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $34 |
1,015%
upside
| 2 | -17% |
0
%
| 26 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $14 |
42%
upside
| 2 | +91% |
0
%
| 26 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $40 |
117%
upside
| 3 | +25% |
0
%
| 22 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $10 |
365%
upside
| 2 | +15% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $8.60 | – | 3 | +46% |
0
%
| 6 Aug ‘25 7 months ago |
|
|
|
Buy
Maintained
| $13 |
12%
upside
| 2 | +56% |
0
%
| 17 Jul ‘25 7 months ago |
|
|
|
Buy
Maintained
| $48 |
63%
upside
| 3 | +15% |
0
%
| 2 Jul ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $47 |
0%
upside
| 1 | -21% |
–
| 30 Apr ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $5 |
205%
upside
| 1 | +28% |
0
%
| 20 Mar ‘25 11 months ago |
|
|
|
Buy
Maintained
| $8 |
248%
upside
| 1 | +36% |
0
%
| 19 Mar ‘25 11 months ago |
|